Exatecan (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Exatecan (Standard)
Description:
Exatecan (Standard) is the analytical standard of Exatecan. This product is intended for research and analytical applications. Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.Product Name Alternative:
DX-8951 (Standard)UNSPSC:
12352005Hazard Statement:
H300, H340, H360Target:
ADC Payload; Reference Standards; TopoisomeraseType:
Reference StandardsRelated Pathways:
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; OthersApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/exatecan-standard.htmlPurity:
99.89Smiles:
O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C5C6=C(CC[C@@H]5N)C(C)=C(F)C=C6N=C4C3=C2)=OMolecular Formula:
C24H22FN3O4Molecular Weight:
435.45Precautions:
H300, H340, H360References & Citations:
[1]Mitsui I, et al. A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo. Jpn J Cancer Res. 1995 Aug;86 (8) :776-82.|[2]Sun FX, et al. Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res. 2003 Jan 1;63 (1) :80-5.|[3]Joto N, et al. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Int J Cancer. 1997 Aug 7;72 (4) :680-6.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, sealed and dry storage, away from light and moistureScientific Category:
Reference StandardsClinical Information:
No Development ReportedCAS Number:
[171335-80-1]
